Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments

NCT06337032 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT06337032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06337032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments
Lead sponsor
Gilead Sciences
Phase
Phase 4
Overall status
Recruiting
Start date
August 27, 2024
Completion date
March 31, 2034
Enrollment
350 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection